Key Financial Inc’s Alaunos Therapeutics TCRT Stock Holding History

Key Financial Inc’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21	Hold	24	–	–	﹤0.01%	1300
2026 Q2	$54	Hold	24	–	–	﹤0.01%	1335
2026 Q1	$69	Hold	24	–	–	﹤0.01%	1371
2025 Q4	$78	Hold	24	–	–	﹤0.01%	1417
2025 Q3	$60	Hold	24	–	–	﹤0.01%	1440
2025 Q2	$116	Buy	+24	New	+$72	﹤0.01%	1395
2024 Q3	–	Sell	-25	Closed	-$171	–	1364
2024 Q2	$171	Hold	25	–	–	﹤0.01%	1298
2024 Q1	$443	Hold	25	–	–	﹤0.01%	1237
2023 Q4	$261	Hold	25	–	–	﹤0.01%	1270
2023 Q3	$486	Hold	25	–	–	﹤0.01%	1251
2023 Q2	$1.88K	Hold	25	–	–	﹤0.01%	1170
2023 Q1	$2.32K	Hold	25	–	–	﹤0.01%	937
2022 Q4	$6.34K	Hold	25	–	–	﹤0.01%	738
2022 Q3	$6K	Hold	25	–	–	﹤0.01%	769
2022 Q2	$5K	Hold	25	–	–	﹤0.01%	814
2022 Q1	$2K	Hold	25	–	–	﹤0.01%	948
2021 Q4	$4K	Hold	25	–	–	﹤0.01%	757
2021 Q3	$7K	Hold	25	–	–	﹤0.01%	662
2021 Q2	$8K	Hold	25	–	–	﹤0.01%	624
2021 Q1	$13K	Hold	25	–	–	0.01%	458
2020 Q4	$9K	Buy	+25	New	+$9.9K	0.01%	478
2020 Q2	–	Sell	-25	Closed	-$9K	–	562
2020 Q1	$9K	Buy	+25	New	+$12.9K	0.01%	424

Other funds holding TCRT

EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

BOK Financial Tulsa, Oklahoma $6.69B AUM 26.84% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

West Paces Advisors Atlanta, Georgia $586M AUM 14.12% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Key Financial Inc's TCRT Position: Q3 2026 in Review

Key Financial Inc held its Alaunos Therapeutics (TCRT) position steady in Q3 2026 at 24 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Key Financial Inc first reported a position in TCRT in Q1 2020 and has held it in 22 quarters since. The position peaked at $13K in Q1 2021. 9 funds tracked by Wall St. Rank hold TCRT as of Q3 2026.

Key Financial Inc held 24 shares of Alaunos Therapeutics worth $21 as of Q3 2026.
Key Financial Inc left its Alaunos Therapeutics share count unchanged in Q3 2026.
Alaunos Therapeutics made up ﹤0.01% of Key Financial Inc's portfolio in Q3 2026, its #1300 holding.
Key Financial Inc first reported a position in Alaunos Therapeutics in Q1 2020 and has held it in 22 quarters since.
Key Financial Inc's Alaunos Therapeutics position peaked at $13K in Q1 2021.
9 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2026.

Based on Key Financial Inc's 13F filing for Q3 2026, filed 2 Nov 2026.